NEWS
See the latest PIR International News, Articles and Network Updates.
PIR International Supports Appointment of Senior Vice President of Chemistry at Amphista Therapeutics
PIR International is pleased to announce the placement of Giles Brown as SVP of Chemistry at Amphista Therapeutics. Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, is applying its proprietary degrader platform to advance new approaches [...]
Sabine Dandiguian – BioLeader Interview
Managing Partner, Jeito Capital (July 2023) Sabine Dandiguian is Managing Partner at Jeito Capital and has over 30 years of experience in the pharmaceutical and medical devices industry. These years of experience have enabled her to acquire in-depth operational [...]
Lars Nieba – BioLeader Interview
Chief Executive Officer, Engimmune Therapeutics (June 2023) Lars Nieba serves as CEO of Engimmune Therapeutics, a biotech company developing soluble, multispecific TCRs as therapy for solid tumours and auto-immune diseases. Lars brings more than 25 years of leadership experience [...]
PIR International appoints SVP, Corporate and Commercial Strategy at NMD Pharma
PIR International is pleased to announce the placement of Daniel Brennan as SVP, Corporate and Commercial Strategy at NMD Pharma. NMD Pharma A/S is a clinical-stage biotech company leading in the development of novel first-in-class therapies for severe neuromuscular disorders. [...]